July 17, 2023 /

Research Row Breakout Session: Approved or on the Horizon – PPMD 2023 Annual Conference

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy


Research Row: Approved or on the Horizon

Join us as we discuss Approved Therapies and those on the Horizon of approval.

  • Santhera Pharmaceuticals (Vamorolone)
  • Italfarmaco ( Givinostat)
  • PTC Pharmaceuticals (Ataluren, Emflaza)
  • Sarepta Therapeutics (Amondys45, Exondys 51, Vyondys53)
  • NS Pharma (Viltepso)
2023 PPMD Annual Conference, Conferences & Meetings
Posted on July 17, 2023
LinkedinPin ItWhatsApp

Join Our Mailing List